logo

EULAR 2017

June 14, 2017


Welcome and introduction
Johanne Martel-Pelletier, PhD

Consensus Recommendations for the Management of Osteoarthritis of the Hand, Hip and Knee: what PANLAR (Pan-American League of Associations of Rheumatology) says
Ingrid Möller, MD, PhD.
Director, Instituto Poal de Reumatología.
Barcelona, Spain


Can biomarkers predict the effect of treatment on cartilage volume loss?
New clinical evidences

Johanne Martel-Pelletier, PhD
Professor of Medicine, University of Montreal
Director, Osteoarthritis Research Unit, University of Montreal
Hospital Research Centre (CRCHUM)
Montreal, Québec, Canada


MOSAIC: 24 MOnth study on Structural changes in knee osteoarthritis
Assessed by mrI with Chondroitin sulphate

Jean-Pierre Pelletier, MD
Professor of Medicine, University of Montreal
Director, Osteoarthritis Research Unit, University of Montreal
Hospital Research Centre (CRCHUM)
Montreal, Québec, Canada


Pharmaceutical grade chondroitin sulphate is as efficacious as celecoxib and better than placebo: results of the ChONdroitin vs CElecoxib vs Placebo Trial (CONCEPT)
Tomasz Blicharski, MD, PhD
Chair and Department of Rehabilitation and Orthopaedics, University of Lublin
Lublin, Poland


Question and Answer session


Concluding Remarks
Johanne Martel-Pelletier, PhD


Any doubt?
Contact us and we will write
you as soon as posible.

Contact